No abstract

No abstract

The aim of this study was to establish diabetic retinopathy correlation with several risk factors. A prospective study including 256 type II diabetic patients who referred to diabetes's clinic was designed. All patients underwent physical & retina examination and then completed questionnaire including duration of DM, cardiovascular disease, stroke, chronic kidney disease, smoking, and kind of treatment, blood pressure, BMI, abdominal & hip circumference. Results of HbA1C, total cholesterol, HDL & LDL cholesterol, TG, FBS, creatinine, 24-h urine microalbumin were recorded. Data were analyzed by SPSS version 17 with K 2 , independent samples T, and logistic regression. Of 256 types II diabetic patients 81 & 175 were men and women respectively. Mean age of subject was 54 ± 10.27. Prevalence of diabetic retinopathy was 22.3% & macula edema 0.5% & PDR 6% & NPDR 14%; diabetic retinopathy was associated with duration of DM & BMI (P = 0, P = 0.43 respectively). Mean of FBS 191 ± 83 vs. 165.7 ± 74.5 (P = 0.03), HbA1c 9.1 ± 2 vs. 8.5 ± 1.9 (P = 0.02), 24-h urine microalbumin 181.2 ± 404.7 vs. 60.2 ± 236 (P = 0.03), Systolic blood pressure 124.3 ± 21.3 vs. 118.5 ± 17.8 (p = 0.04) differed between diabetic patients with or without diabetic retinopathy. There were no significant difference between subject with & without diabetic retinopathy in total cholesterol LDL, HDL, TG, Cr, Diastolic BP, types of treatment, cardiovascular disease, chronic kidney disease, stroke & smoking. This study showed prevalence of diabetic retinopathy was high and it associated with duration of DM, BMI, FBS, HbA1C, 24-h urine albumin, and systolic blood pressure.

Background: Accurate evaluation of response to treatment in differentiated thyroid cancer (DTC) is the sine qua non of preventing over-treatment in low-risk patients and implementing appropriate interventions in high-risk individuals. Objectives: This study aimed to assess the response to therapy in DTC patients based on dynamic stratification method. Methods: In this cross-sectional study, 154 medical records of subjects with DTC (with at least 6 months after total thyroidectomy) and referred to endocrinology clinics in Ahvaz, Iran, from April 2020 to May 2021 were examined. Patients were stratified according to a dynamic risk stratification system (informed by their specific clinical, histopathological, and ultrasonography findings, and other diagnostic imagines) into four groups: Excellent response (ER), indeterminate response (IR), biochemical incomplete response (BIR), and structural incomplete response (SIR). Results: For a mean follow-up period of 28.59 months, excellent response to treatment was observed in 92 patients (59.7%), indeterminate response to treatment was found in 32 patients (20.8%), biochemical incomplete response was detected in 2 patients (1.3%), and structural incomplete response was seen in 28 patients (18.2%). In the group with low risk of recurrence, ER and IR were observed in 79.2% and 15.6% of the patients, respectively (P < 0.0001). In the group with an intermediate risk of recurrence, ER was found in 32% of the patients, while IR and SIR + BIR were seen in 34% and 34% of the patients, respectively (P < 0.0001). No cases of ER or IR were observed in the group with high risk (P = 0.001). Conclusions: In sum, response to treatment significantly varied based on dynamic risk stratification, with ER being highest in the low-risk group, less likely in moderate risk group, and undetected in the high-risk group.

Introduction: The prevalence of cardiovascular diseases increases with age in women, especially at menopause. Metabolic syndrome is one of the important factors that cause heart disease. Therefore, the importance screening of people at risk of this syndrome, especially with cheap tests, led to the introduction of new cardio metabolic indicators such as AIP, TyG and WWI. Also, due to the importance of healthy eating and physical activity in preventing metabolic syndrome, more emphasis should be placed on their use.Methods In this cross-sectional study, the number of 4732 women participating in the Hoveyzeh cohort study, after considering the entry and exit criteria, were placed into three groups: pre-menopausal (n = 736), menopausal (n = 396) and post-menopausal (n = 917).Results The prevalence of metabolic syndrome was 43.3%, 55.6%, and 62.8% in pre menopause, menopause, and post menopause, respectively. The prevalence of hypertension (50.2%), dyslipidemia (61.2%), diabetes (37.7%) and abdominal obesity according to the Iranian definition (75.9%) was higher after menopause than before menopause. Cardiovascular disease had the highest prevalence after menopause (23%). The WWI index had the highest OR among the indices with a value of 2.94 and 1.93 in menopause and after menopause, respectively. (P < 0.001). In the HEI-2015 survey, the consumption of total fruit, vegetables, seafood and protein in premenopausal women was more than after menopause, and the consumption of foods containing sugar in menopause was more than in premenopausal women. The amount of physical activity had the highest and lowest values ​​in pre menopause and post-menopause, respectively. (P < 0.001)Conclusion Menopause leads to an increase in the prevalence of metabolic syndrome. The indices of AIP, TyG index, WWI and physical activity increase in women after menopause compared to before menopause. TyG-INDEX ،WWI ،HEI-2015 healthy eating index in this study did not show significant differences between groups after multi-regression analysis.